RxDoctor Payments DataLook up a doctor →

Luis Fandos, MD

Interventional Pain Medicine · Babylon, NYNPI 1376572594

Payments from drug & device makers

$31,646in general payments, 2019–2025

Across 893 payments — averaging $35.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • International Rehabilitative Sciences, Inc$8K
  • Elliquence, LLC$5K
  • Relievant Medsystems, Inc.$3K
  • Boston Scientific$3K
  • Abbott$1K
  • AbbVie$1K
  • plus $11K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
International Rehabilitative Sciences, Inc2$7,620
Elliquence, LLC1$5,000
Relievant Medsystems, Inc.46$2,884
Boston Scientific137$2,781
Abbott94$1,300
AbbVie(2 entities)63$1,136
Medtronic(2 entities)73$1,126
Nevro Corp.80$911
Scilex Pharmaceuticals Inc.34$673
Spinefrontier, Inc.2$595
Biodelivery Sciences International, Inc.63$527
Saluda Medical Americas, Inc.5$456
Collegium Pharmaceutical, Inc.27$407
Nalu Medical, Inc.13$384
Averitas Pharma Inc.16$368
Biotronik NRO, Inc.5$360
Stimwave Technologies Incorporated3$332
MML US, Inc.11$308
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC18$271
Zyla Life Sciences, Inc.18$265
Forte Bio-pharma LLC5$258
Vertos Medical, Inc.13$230
Si-bone, Inc.6$223
Virtus Pharmaceuticals LLC17$223
Johnson & Johnson10$222
Amgen(2 entities)12$205
Axonics, Inc.2$185
Pfizer10$177
Fidia Pharma USA Inc.11$166
Foundation Fusion Solutions, LLC2$148
Protega Pharmaceutials Inc7$142
Novartis7$141
Redhill Biopharma Inc.6$123
Painteq LLC4$115
IBSA Pharma Inc.5$90
Biohaven Pharmaceuticals, Inc.4$88
Azurity Pharmaceuticals, Inc.4$84
Lundbeck LLC4$71
Valinor Pharma, LLC4$71
Biohaven Pharmaceutical Holding Company Ltd.3$70
Daiichi Sankyo Inc.4$70
Baudax Bio Inc.3$61
Assertio Therapeutics, Inc.4$59
GRT US Holding, Inc.3$55
Intrinsic Therapeutics1$55
MDD US Operations, LLC2$51
Arbor Pharmaceuticals, Inc.3$48
Bioventus LLC2$47
Axsome Therapeutics, Inc.2$46
Curonix LLC1$46
Kowa Pharmaceuticals America, Inc.3$44
Inspire Medical Systems, Inc.2$37
Takeda Pharmaceuticals U.S.A., Inc.2$32
USWM, LLC2$31
Vertex1$31
Supernus Pharmaceuticals, Inc.2$30
Sentynl Therapeutics, Inc.2$30
Merck1$24
Almatica Pharma LLC1$23
Stryker1$23

How this compares

$31,646 in reported general payments places this provider in the 90th percentile of 132 interventional pain medicine providers in New York.

See all interventional pain medicine providers in New York →

Medicare billing

Part B allowed, 2024
$921,476
Medicare patients
549
Services billed
6,599

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional pain medicine in Babylon

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →